Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob McMurray

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Neurology|September 19, 2017
Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizuresVicente Villanueva, Martin Holtkamp, Norman Delanty, et al.
Journal of the Neurological Sciences|May 26, 2019
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli studyColin P Doherty, Sylvain Rheims, Giovanni Assenza, et al.
Epilepsy Research|May 28, 2021
Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli studyFrancisco Sales, Norman Delanty, Oriano Mecarelli, et al.
Seizure|July 1, 2022
Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT studyWendyl D'Souza, Taoufik Alsaadi, Javier Montoya, et al.
Epilepsy Research|March 16, 2024
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension studyNorman Delanty, Rajiv Mohanraj, Rohit Shankar, et al.
Epilepsia|April 28, 2023
Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practiceEugen Trinka, Taoufik Alsaadi, Hiroko Goji, et al.
Journal of Neurology|August 24, 2021
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practiceVicente Villanueva, Wendyl D'Souza, Hiroko Goji, et al.
Frontiers in Neurology|April 17, 2023
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT studyClaudio Liguori, Estevo Santamarina, Adam Strzelczyk, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Neurology|September 19, 2017
Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizuresVicente Villanueva, Martin Holtkamp, Norman Delanty, et al.
Journal of the Neurological Sciences|May 26, 2019
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli studyColin P Doherty, Sylvain Rheims, Giovanni Assenza, et al.
Epilepsy Research|May 28, 2021
Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli studyFrancisco Sales, Norman Delanty, Oriano Mecarelli, et al.
Seizure|July 1, 2022
Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT studyWendyl D'Souza, Taoufik Alsaadi, Javier Montoya, et al.
Epilepsy Research|March 16, 2024
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension studyNorman Delanty, Rajiv Mohanraj, Rohit Shankar, et al.
Epilepsia|April 28, 2023
Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practiceEugen Trinka, Taoufik Alsaadi, Hiroko Goji, et al.
Journal of Neurology|August 24, 2021
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practiceVicente Villanueva, Wendyl D'Souza, Hiroko Goji, et al.
Frontiers in Neurology|April 17, 2023
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT studyClaudio Liguori, Estevo Santamarina, Adam Strzelczyk, et al.
Pageof 2